Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stroke Rehabilomics Study: Epigenetics and Genetics Characterization of the BDNF and SLC6A4 Genes in Patients Undergoing Robotic Rehabilitation Treatment

NCT04223180 is registered in ClinicalTrials.gov with Fondazione Don Carlo Gnocchi ETS as lead sponsor.

NCT NCT04223180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04223180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stroke Rehabilomics Study: Epigenetics and Genetics Characterization of the BDNF and SLC6A4 Genes in Patients Undergoing Robotic Rehabilitation Treatment
Lead sponsor
Fondazione Don Carlo Gnocchi ETS
Phase
Observational
Overall status
Completed
Start date
January 20, 2020
Completion date
January 31, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke